Poland· PL-100469198
Candesartan Cilexetil + Amlodipine + Hydrochlorothiazide Adamed
A candesartan, amlodipin und hydrochlorothiazid product containing candesartanum cilexetili + amlodipinum + hydrochlorothiazidum, registered in Poland by Adamed Pharma S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Candesartanum cilexetili + Amlodipinum + Hydrochlorothiazidum
- Manufacturer
- Adamed Pharma S.A.
- Country
- Poland (PL)
- ATC code
- C09DX06
- ATC class
- Candesartan, Amlodipin und Hydrochlorothiazid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
- gtin05909991551186
- gtin05909991551193
- gtin05909991551209
- gtin05909991551216
- gtin05909991551223
- gtin05909991551230
- gtin05909991551247
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C09DX06
Candesartan, amlodipin und hydrochlorothiazid, as other registers publish it.
- PolandCandesartan cilexetil + Amlodipine + HCT +pharmapharma arzneimittel gmbh
- PolandCandesartan cilexetil + Amlodipine + HCT +pharmapharma arzneimittel gmbh
- PolandCandesartan cilexetil + Amlodipine + HCT SandozSandoz Polska Sp. z o.o.
- PolandCandesartan cilexetil + Amlodipine + HCT SandozSandoz Polska Sp. z o.o.
- PolandCandesartan Cilexetil + Amlodipine + Hydrochlorothiazide AdamedAdamed Pharma S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8dfa2a9f-3c33-45a7-b980-f6d6b7fa2687 GET /v1/drugs/8dfa2a9f-3c33-45a7-b980-f6d6b7fa2687?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "16 mg + 5 mg + 12,5 mg",
"packaging": "05909991551186 ¦ Rp ¦ 157372\n30 kaps.\n05909991551193 ¦ Rp ¦ 157373\n28 kaps.\n05909991551209 ¦ Rp ¦ 157374\n7 kaps.\n05909991551216 ¦ Rp ¦ 157375\n100 kaps.\n05909991551223 ¦ Rp ¦ 157376\n10 kaps.\n05909991551230 ¦ Rp ¦ 157377\n90 kaps.\n05909991551247 ¦ Rp ¦ 157378\n60 kaps.",
"substance": "Candesartanum cilexetili 16 mg + Amlodipinum 5 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Candesartanum cilexetili + Amlodipinum + Hydrochlorothiazidum",
"pl_product_id": "100469198",
"pozwolenie_nr": "28521",
"auth_procedure": "DCP",
"authorisation_validity": "2029-07-23"
}See everything about candesartan, amlodipin und hydrochlorothiazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.